I Don't Have a Gallbladder Any More. Does the GLP-1 Warning Still Apply?

The question the label doesn't answer

My prescribing information has an entire numbered section about acute gallbladder disease. I read it properly one evening, the way you do at eleven at night, and I got stuck on an obvious question it never addresses: what does any of this mean if your gallbladder is already gone?

I could not find a straight answer, so I went and read the actual studies. Here is what I found, including the part where it turns out nobody has really looked.

What the warning is actually made of

The warning is not vague. In the two Zepbound weight-reduction trials, cholelithiasis — gallstones — was reported in 1.1% of people on the drug against 1% on placebo, cholecystitis in 0.7% against 0.2%, and gallbladder removal itself in 0.2% against none on placebo. The label adds that these events were associated with the weight reduction¹.

The bigger picture comes from a meta-analysis in JAMA Internal Medicine that pooled 76 randomized trials and 103,371 people².

Two things jump out of that table. Taking these drugs for weight loss carries roughly double the gallbladder risk of taking them for diabetes, and at lower doses the risk essentially disappears².

Why most of it stops applying to me — and the catch

Read down the list of what that risk is made of. Gallstones. Gallbladder inflammation. Gallbladder removal. Every one of those needs a gallbladder to happen to. If yours is out, the bulk of the warning is describing an organ you no longer own, and that is a real, specific piece of reassurance rather than a hedge.

Here is the catch I did not expect. That meta-analysis counted cholecystectomy — the surgery — as one of its outcomes². Those trials were tracking people who went on to have the operation, which means the entire evidence base was built from people who still had the organ at the start. None of it describes women who were already without one.

So the honest answer is not "you're fine." It is that the specific risk the label warns about mostly cannot happen to you, and that nobody has studied what does.

What replaces it

This is the part I would actually want to know. Persistent or new symptoms after gallbladder removal are common enough to have their own name — post-cholecystectomy syndrome — and a 2025 review puts it at up to 47% of patients, with no consensus on how to diagnose or treat it even though it was described in 1947³.

One of its recognized forms is bile acid diarrhea. Without a gallbladder to store bile, it drips continuously into your gut, and for some people the result is urgent, frequent, loose stools. Losing the gallbladder is a well-documented secondary cause of it⁴.

Now put that next to a drug where diarrhea is one of the most commonly reported side effects. Two entirely separate causes, producing symptoms that feel identical. You will not be able to tell by feel which one you are having, and I think that is the practical thing to walk in knowing — not because it is alarming, but because "it's just the GLP-1" is an assumption worth checking rather than the obvious conclusion.

The part that genuinely surprised me

Bile acid diarrhea is usually treated with bile acid sequestrants. But the same review notes that liraglutide — a GLP-1 receptor agonist, the same class as my medication — is also effective for it. What it does not know is the mechanism, or whether the effect extends to the other drugs in the class⁴.

I want to be careful with that, because it would be easy to read it as "my drug treats the problem." It is one drug in the class, and the review says plainly that whether this is a class effect is unclear⁴. Nobody should start or stay on a GLP-1 expecting it to fix bile acid diarrhea. But it does mean the relationship between these drugs and post-gallbladder guts is more interesting than a simple warning label, and worth raising with someone rather than assuming.

What I would ask

If I were starting one of these without a gallbladder, I would ask my prescriber three things. Whether the dose matters here the way it does for everyone else, given how sharply the risk fell at lower doses². Whether persistent diarrhea should be investigated as bile acid diarrhea rather than filed under drug side effects. And what the plan is if it does not settle, since bile acid diarrhea has actual treatments and waiting it out is not one of them.

None of this is medical advice — I am a mother who reads studies, not a clinician. But I would rather walk in with the specific question than be told the general answer.